Raffaella Albano
Candiolo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
New Candidate Reference Measurement Procedures for MET CNV Detection and Quantification Using Digital PCR.
Journal: Biological procedures online
Published: November 04, 2025
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.
Journal: Molecular oncology
Published: November 04, 2022
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.
Journal: Cell reports
Published: September 16, 2022
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma.
Journal: Cell reports
Published: September 21, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro.
Journal: British journal of pharmacology
Published: September 07, 2018
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
Journal: EMBO molecular medicine
Published: May 04, 2016
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy.
Journal: Cell death & disease
Published: August 19, 2013
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
Journal: Cancer research
Published: June 29, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026